Bay Street News, June 3rd, 2020

SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients […]

Not for distribution to U.S. news wire services or dissemination in the United StatesVANCOUVER, British Columbia, June 03, 2020 (GLOBE […]

– High Variability in Levels of Biomarkers in Control Arm of Phase 2b Study May Drive Reassessment of Overall Study […]

MONMOUTH JUNCTION, N.J., June 03, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the Company), a late clinical-stage biopharmaceutical company working to […]

CHESTERBROOK, Pa., June 03, 2020 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and […]

— Phase 3 study in eosinophilic gastritis and/or eosinophilic duodenitis and Phase 2/3 study in eosinophilic esophagitis — — Top-line safety […]

– DSMB Reviewed Over 500 Patients’ Data in Second Interim Analysis to Assess Overall Benefit / Risk with Plinabulin in […]

Topline data expected by year-end 2020Applications for US and EU regulatory approval planned for 2021BOSTON, June 03, 2020 (GLOBE NEWSWIRE) […]

SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological […]

MARTINSVILLE, Va., June 03, 2020 (GLOBE NEWSWIRE) — Hooker Furniture (Nasdaq-GS:HOFT) announced that due to the COVID-19 pandemic and related […]